文献速递主动脉疾病

非创伤性破裂性B型主动脉夹层的TEVAR治疗:欧洲多中心研究

TEVAR for Nontraumatic Ruptured Type B Aortic Dissections: A European Multicentre Study.
PubMed 文献 · J Endovasc Ther · 2026-09-20

30天死亡率为20.6%,90天死亡率为35.3%;存活过30天的患者中期随访17.5个月(IQR 4.75–39.5),3年时41.2%死亡,其中8例为主动脉相关死亡。远端支架着陆于夹层主动脉与未夹层主动脉的生存率无差异(42.9% vs 57.1%;结论提示破裂性TBAD需快速止血时,严格的健康-健康着陆可能并非必需。

要点

  • 破裂性TBAD行TEVAR的30天死亡率为20.6%,90天死亡率为35.3%。
  • 存活过30天的患者3年死亡率为41.2%,其中8例为主动脉相关死亡。

核心结论

  • 破裂性TBAD行TEVAR的围手术期90天死亡率高,但存活过该期的患者中期结局可接受。
  • 需要快速控制出血时,严格的健康-健康远端着陆可能并非总是必需。

研究设计与样本

  • 破裂定义为术前CT显示血胸(30–45 HU),伴或不伴主动脉壁破损或活动性造影剂外渗。

主要发现

  • 远端着陆区位于夹层主动脉内者20例(58.8%);行内脏分支血运重建者14例(41.2%),有意覆盖左锁骨下动脉者15例(44.1%)。
  • 30天死亡率为20.6%(n=7),90天死亡率为35.3%(n=12);存活过30天者中位随访17.5个月(IQR 4.75–39.5)。
  • 3年随访时14例(41.2%)死亡,其中8例为主动脉相关死亡;7例(20.6%)接受主动脉再干预。

临床怎么用

  • TEVAR仍是破裂性TBAD的主要治疗方式,但围手术期风险高,需向患者及家属交代90天死亡率达35.3%。
  • 存活过早期危重窗口的患者中期结局可接受,支持在充分评估后继续积极干预。
  • 紧急止血时远端着陆于夹层主动脉未损害生存,可优先快速控制出血而非严格追求健康-健康着陆。

局限性

  • 原文未报告前瞻性验证或长期随访数据,需前瞻性注册和国际协作研究进一步明确患者选择与治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ruptured acute type B aortic dissection (TBAD) is rare, carries high mortality risk, and presents major challenges with limited supporting evidence. This study evaluated early and mid-term outcomes after thoracic endovascular aortic repair (TEVAR) for nontraumatic ruptured TBAD. METHODS: This retrospective multicentre study included patients undergoing TEVAR for nontraumatic ruptured TBAD at 6 vascular centres (2010-2023). Rupture was defined as haemothorax (30-45 HU) on preoperative computed tomography with or without aortic wall disruption or active extravasation. Outcomes were 30-day and mid-term mortality, reinterventions, and complications. RESULTS: Thirty-four patients treated with TEVAR for nontraumatic ruptured TBAD were identified; 11 haemodynamically unstable. Distal dissection extended to Lombardi zone ≤5 in 12 (35.3%), and ≥6 in 22 (64.7%), and distal landing zone was within dissected aorta in 20 (58.8%). Visceral branch revascularisation and intentional coverage of the left subclavian artery were performed in 14 (41.2%) and 15 (44.1%) patients, respectively. Median follow-up for those surviving the first 30-day period was 17.5 months (interquartile range [IQR] 4.75-39.5). Thirty-day mortality was 20.6% (n = 7) and 90-day mortality 35.3% (n = 12). At 3-year follow-up, 14 patients (41.2%) had died, of which 8 patients suffered an aortic-related death. No difference in survival between distal TEVAR landing in non-dissected versus dissected aorta (42.9% vs 57.1%; log-rank P = .738) was observed. Seven patients had aortic reinterventions (20.6%). CONCLUSION: In this multicentre cohort of ruptured TBAD treated with TEVAR, the perioperative mortality at 90 days was high, but patients surviving that period had an acceptable mid-term outcome. These findings suggests that strict healthy-to-healthy landing may not always be necessary when rapid haemorrhage control is required in ruptured TBAD. Prospective registries and international collaborative studies are needed to refine patient selection, treatment strategies and long-term outcomes.Clinical ImpactEvidence regarding TEVAR for ruptured TBAD remains limited. The present multicentre study therefore provides valuable new insights with real-world outcomes across multiple vascular institutions. The findings suggests that strict healthy-to-healthy landing may not always be necessary when rapid haemorrhage control should be prioritized in ruptured TBAD.TEVAR remains the primary treatment for ruptured TBAD, but perioperative risk is substantial, with a 90-day mortality of 35%. Clinicians should recognize that patients surviving this critical early window have acceptable mid-term outcomes, supporting continued aggressive intervention despite the early risk. In this study distal landing within dissected aorta does not compromise survival compared to healthy-to-healthy landing, challenging conventional anatomical dogma. This finding gives clinicians flexibility to prioritize rapid haemorrhage control over strict landing-zone criteria during emergent repair, particularly when unstable anatomy limits ideal distal fixation, without sacrificing longer-term survival benefit.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Lilja E, Mani K, Wanhainen A, et al. TEVAR for Nontraumatic Ruptured Type B Aortic Dissections: A European Multicentre Study. J Endovasc Ther. 2026. PMID: 42764722. doi:10.1177/15266028261484805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。